Cargando…
Can anti-thyroglobulin antibody (anti-Tg) be a tumor marker for recurrence in papillary thyroid carcinoma (PTC) in patients without autoimmune thyroiditis (AIT)?: A case report
INTRODUCTION: Thyroid carcinoma is the most common malignancy of the endocrine system, accounting for 1% of all newly diagnosed cancers. Thyroglobulin (Tg) is a tumor marker for papillary thyroid carcinoma (PTC) if the anti-thyroglobulin antibody (anti-Tg) is negative. In autoimmune thyroiditis (AIT...
Autores principales: | Begüm Bahçecioğlu, Adile, Faik Erdoğan, Murat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653130/ http://dx.doi.org/10.1210/jcemcr/luac014.061 |
Ejemplares similares
-
OR27-5 The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence
por: Yin, Ngwe, et al.
Publicado: (2019) -
MON-495 Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma
por: Viola, Nicola, et al.
Publicado: (2020) -
SAT546 Papillary Thyroid Cancer Surveillance: Thyroglobulin Levels Affected by HAMA
por: Perez, Julienne Sanchez, et al.
Publicado: (2023) -
SAT540 A Case of Simultaneous Medullary Thyroid Cancer (MTC) And Papillary Thyroid Cancer (PTC) In a Patient With Germline RET Mutation
por: Vaghasia, Nishit, et al.
Publicado: (2023) -
Utility of Stimulated Thyroglobulin in the Differentiate Thyroid Cancer
por: Romero, Fabiola, et al.
Publicado: (2021)